FrancophonIA/ELRC3.0 huggingface dataset:
English: Calves, lambs, pigs, poultry
Estonian: Veised (vasikad), lambad (talled), sead, kanad
English: Calves, pigs, broilers, turkeys, laying hens, rabbits
Estonian: Vasikad, sead, broilerid, kalkunid, munakanad, küülikud
English: Strength
Estonian: Vasikad
English: Calves, piglets and weaners, domestic fowl - broilers
Estonian: Vasikad, põrsad ja võõrdepõrsad, kodukanad - broilerid
English: Calves, piglets, lambs, rabbits, poultry
Estonian: Vasikad, põrsad, lambatalled, küülikud, kodulinnud
English: Emulsion for oral use
Estonian: Suukaudne emulsioon
English: Pigs, poultry, suckling calves
Estonian: Sead, kodulinnud, imevad vasikad
English: 1107 Budapest,
Estonian: 1107 Budapest, Szállás u. 5., Ungari
English: Calves, piglets, chicken (broilers)
Estonian: Vasikad, põrsad, kanad (broilerid)
English: Oral solution (Concentrate for oral solution for use in drinking water)
Estonian: Suukaudne lahus (suukaudse lahuse kontsentraat joogivees kasutamiseks)
English: Pigs, chicken, cattle (calves)
Estonian: Sead, kanad, veised (vasikad)
English: Sant Hipòlit km 71, 08503, Gurb-Vic,
Estonian: Sant Hipòlit km 71, 08503, Gurb-Vic, Barcelona,
English: 5 000 000 IU/ml
Estonian: 5 million IU/g
English: Pigs, poultry
Estonian: Põrsad, kodulinnud
English: Pigs, piglets, chicken (broilers), turkey
Estonian: Sead, põrsad, kanad (broilerid), kalkunid
English: КОЛИВЕТ ПЕРОРАЛЕН РАЗТВОР Colistin sulphate
Estonian: КОЛИВЕТ ПЕРОРАЛЕН РАЗТВОР
English: Powder for administration in drinking water
Estonian: Pulber joogivees manustamiseks
English: Pigs (up to 35 kg), broilers, turkeys, laying hens, rabbits
Estonian: Sead (kuni 35 kg), broilerid, kalkunid, munakanad, küülikud
English: Belgium Eurovet N.V. Poorthoevestraat 4
Estonian: Eurovet N.V.
English: Calves, pigs (up to 35 kg), broilers, turkeys, hens and rabbits
Estonian: Vasikad, sead (kuni 35 kg), broilerid, kalkunid, kanad ja küülikud
English: Calves, pigs (up to 35 kg), broilers, turkeys, laying hens, rabbits
Estonian: Vasikad, sead (kuni 35 kg), broilerid, kalkunid, munakanad, küülikud
English: Cattle (calves), pigs, chicken
Estonian: Veised (vasikad), sead (põrsad), kanad
English: Slovakia Divasa - Farmavic S.A. Ctra.
Estonian: Divasa - Farmavic S.A. Ctra.
English: Piglets up to 35 kg of weight, broilers, turkeys, laying hens and rabbits
Estonian: Põrsad kehamassiga kuni 35 kg, broilerid, kalkunid, munakanad ja küülikud
English: Calves, pigs, broilers, turkeys, laying hens
Estonian: Vasikad, sead, broilerid, kalkunid, munakanad
English: Oral solution Calves, pigs (up to 35kg), broilers, turkeys, laying hens and rabbits
Estonian: Suukaudne lahus Vasikad, sead (kuni 35 kg), broilerid, kalkunid, munakanad ja küülikud
English: Piglets, calves, chicken (broilers)
Estonian: Põrsad, vasikad, kanad (broilerid)
English: Calves, lambs, kid (goat), pigs, rabbits, poultry, turkeys, ducks, guinea hens, pheasants, partridges, geese, quails
Estonian: Vasikad, lambatalled, kitsetalled, sead, küülikud, kodulinnud, kalkunid, pardid, pärlkanad, faasanid, nurmkanad, haned, vutid
English: Lambs, quails, ducks, kid (goat), turkeys, pheasants, rabbits, geese, partidges, guinea hens, pigs, poultry
Estonian: Lambatalled, vutid, pardid, kitsetalled, kalkunid, faasanid, küülikud, haned, nurmkanad, pärlkanad, sead, kodulinnud
English: Pigs (up to 35 kg), broilers, laying hens, turkeys and rabbits
Estonian: Sead (kuni 35 kg), broilerid, munakanad, kalkunid ja küülikud
English: Denmark
Estonian: Rootsi
English: Calves, lambs, pigs and poultry (chicken broilers)
Estonian: Vasikad, lambatalled, sead ja kodulinnud (kanabroilerid)
English: Pigs (up to 35 kg), broilers, turkeys, laying hens and rabbits
Estonian: Sead (kuni 35 kg), broilerid, kalkunid, munakanad ja küülikud
English: To be administered dissolved in drinking water or liquid food
Estonian: Suukaudne lahus joogivees või piimas manustamiseks
English: Calves, pigs (up to 35 kg), broilers, turkeys, guinea fowl, ducks, hens and rabbits
Estonian: Vasikad, sead (kuni 35 kg), broilerid, kalkunid, pärlkanad, pardid, kanad ja küülikud
English: Belgium Sogeval 200 Avenue de Mayenne Zone Industrielle des Touches
Estonian: Ühendkuningriik Sogeval 200 Avenue de Mayenne Zone Industrielle des Touches
English: Calves, pigs, chicken, lambs
Estonian: Vasikad, sead, kanad, kalkunid
English: Calves, pigs (up to 35 kg), broilers, laying hens, turkeys and rabbits
Estonian: Vasikad, sead (kuni 35 kg), broilerid, munakanad, kalkunid ja küülikud
English: Pigs, calves, poultry
Estonian: Sead, kalkunid, kanad
English: Calves, lambs, pigs and chickens
Estonian: Vasikad, lambatalled, sead ja kanad
English: Hungary Biopol Fejlesztő és Kereskedelmi Kft.
Estonian: Lavet Gyógyszergyártó Kft.
English: Romania DOPHARMA B.V. Zalmweg 24,P.O.
Estonian: Zalmweg 24,P.O.
English: Non-ruminating calves
Estonian: Mittemäletsevad vasikad
English: Page 2/2©EMEA 2009
Estonian: Lk 2/2©EMEA 2009
English: The withdrawal period is zero days.
Estonian: Keeluperioodi kestus on null päeva.
English: It may also cause a temporary increase in body temperature.
Estonian: See võib põhjustada ka ajutist kehatemperatuuri tõusu.
English: If pain persists for more than 12 hours after medical examination, seek medical advice again.
Estonian: Kui valu püsib rohkem kui 12 tundi pärast meditsiinilist läbivaatust, tuleb uuesti arsti poole pöörduda
English: It is given as three injections into the neck muscle: the first is given 45 days before the cow is expected to give birth, the second 35 days later, and the third after another 62 days.
Estonian: Ravimit manustatakse kolme süstena kaelalihasesse: esimene süst manustatakse 45 päeva enne eeldatavat poegimiskuupäeva, teine süst 35 päeva pärast ja kolmas süst veel 62 päeva pärast.
English: This summary was last updated on 11 February 2009.
Estonian: Kokkuvõtte viimane uuendus: 11/02/2009.
English: If you are accidentally injected with this product, seek medical advice promptly, even if only a very small amount is injected, and take the Package Leaflet with you.
Estonian: Kui teid süstiti juhuslikult selle ravimiga, pöörduge viivitamata arsti poole ka siis, kui süstiti väga väike kogus, ning võtke kaasa pakendi infoleht.
English: In rare cases, this could result in the loss of the affected finger if prompt medical attention is not given.
Estonian: Harvadel juhtudel võib süstimine viia ka kahjustatud sõrme kaotuseni, kui ei pöörduta viivitamatult arsti poole.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) STARTVAC EPAR summary for the public
Estonian: EUROOPA AVALIK HINDAMISARUANNE STARTVAC Kokkuvõte üldsusele
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Startvac to Laboratorios Hipra, S.A. on 11 February 2009.
Estonian: Euroopa Komisjon väljastas Startvaci müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele Laboratorios Hipra, S.A. 11/02/2009.
English: Milk can be taken at any time after injection.
Estonian: Piima võib kasutada ükskõik mis ajal pärast süstimist.
English: The company has carried out a number of studies, including one main study that looked at the effectiveness of Startvac in dairy cows under field conditions.
Estonian: Ettevõte on teinud mitmeid uuringuid, sealhulgas üks suur uuring, milles vaadeldi Startvaci efektiivsust piimalehmadel tegelikus kasutus-keskkonnas.
English: Accidental injection or self-injection could cause severe pain and swelling, particularly if the vaccine is injected into a joint or finger.
Estonian: Juhuslik süstimine või enesele süstimine võib põhjustada tugevat valu ja paistetust, eriti kui vaktsiin süstitakse liigesesse või sõrme.
English: The full course of injections should be repeated for every pregnancy.
Estonian: Kogu süstekuuri tuleb korrata iga tiinuse korral.
English: Startvac is a vaccine.
Estonian: Startvac on vaktsiin.
English: The antibodies will help to fight the bacteria, preventing mastitis occurring or reducing the severity of its symptoms.
Estonian: Antikehad aitavad võidelda bakteritega, takistades mastiidi teket või vähendades selle sümptomite raskust.
English: The vaccine also contains an ‘adjuvant' (liquid paraffin) to stimulate a better response.
Estonian: Vaktsiin sisaldab ka adjuvanti (vedelat parafiini) immuunsüsteemi parema vastusreaktsiooni stimuleerimiseks.
English: Startvac contains liquid paraffin (a type of mineral oil).
Estonian: Startvac sisaldab vedelat parafiini (teatud tüüpi mineraalõli).
English: Why has Startvac been approved?
Estonian: Miks Startvac heaks kiideti?
English: Startvac is given to all healthy cows in a herd, during and after pregnancy.
Estonian: Startvaci manustatakse karja kõigile tervetele lehmadele, sealhulgas tiinuse ajal ja pärast seda.
English: Startvac is an emulsion for injection that is available in vials (3, 10 and 50 ml).
Estonian: Startvac on süsteemulsioon, mida turustatakse viaalides (3 ml, 10 ja 50 ml).
English: The vaccine may cause temporary swelling and pain at the site of injection.
Estonian: Vaktsiin võib süstekohas põhjustada ajutist paistetust ja valu.
English: The strengthened immunity reduces the number of cows affected and the severity of clinical signs.
Estonian: Tugevdatud immuunsus vähendab haigusest haaratud lehmade arvu ja kliiniliste nähtude raskust.
English: The animal can be slaughtered for food at any time after injection.
Estonian: Looma võib toiduks kasutamise otstarbel tappa üks kõik mis ajal pärast süstimist.
English: In the future, the immune system will be able to make the antibodies more quickly when it is exposed to the bacteria again.
Estonian: Kui immuunsüsteem puutub bakteritega kokku hiljem uuesti, on see võimeline tekitama antikehi kiiremini.
English: When it is given to a cow, the animal's immune system recognises the bacteria as ‘foreign' and makes antibodies against them.
Estonian: Kui ravimit manustatakse lehmadele, peab immuunsüsteem bakterite ja viiruste osi võõraks ning tekitab nende vastu antikehi.
English: Startvac is a vaccine for cows that contains inactivated (killed) bacteria called Escherichia coli and Staphylococcus aureus.
Estonian: Startvac on vaktsiin lehmadele, mis sisaldab inaktiveeritud (hävitatud) baktereid Escherichia coli ja Staphylococcus aureus.
English: Startvac is used to strengthen the immunity of whole herds of otherwise healthy dairy cows in herds that are known to have problems due to mastitis (inflammation of the udder due to infection).
Estonian: Startvaci kasutatakse immuunsüsteemi tugevdamiseks muidu tervete piimalehmade karjades, kui neis karjades on teadaolevalt esinenud mastiidi (infektsiooni põhjustatud udarapõletik) põhjustatud probleeme.
English: What is the risk associated with Startvac?
Estonian: Mis riskid Startvaciga kaasnevad?
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Startvac exceed the risks for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and severity of the clinical signs of clinical mastitis caused by Staphylococcus aureus, coliforms and coagulase-negative staphylococci, and recommended that Startvac be given a marketing authorisation.
Estonian: Veterinaarravimite komitee otsustas, et Startvaci kasulikkus selle kasutamisel tervete lehmade ja mullikate karja immuniseerimisel piimakarjades, milles esineb Staphylococcus aureus'e, koliformsete bakterite ja koagulaasnegatiivsete stafülokokkide poolt põhjustatud korduva mastiidi probleem, subkliinilise mastiidi ja kliinilise mastiidi esinemissageduse ja kliiniliste tunnuste raskuse vähendamisel, on suurem kui sellega kaasnevad riskid, ning Startvacile soovitati anda müügiluba.
English: How does Startvac work?
Estonian: Kuidas Startvac toimib?
English: Startvac contains killed forms of two bacteria that normally cause mastitis (Escherichia coli and Staphylococcus aureus).
Estonian: Startvac sisaldab tavaliselt mastiiti põhjustava kahe bakteri (Escherichia coli ja Staphylococcus aureus) hävitatud vorme.
English: Startvac injections did not have any harmful effects on pregnancy or giving birth, or on the cows' calves.
Estonian: Startvaci süstetel ei olnud kahjulikku mõju tiinusele, poegimisele ega vasikatele.
English: Vaccination with Startvac also led to an increased number of cows being cured of the infection, a reduction in the number of cows that needed treatment for mastitis, and an increase in the quantity and quality of milk production.
Estonian: Vaktsineerimisel Startvaciga suurenes infektsioonist paranenud lehmade arv, mastiidi ravi vajanud lehmade arv vähenes ning piimatoodangu kogus ja kvaliteet paranesid.
English: The studies showed that Startvac reduced the number of cows with mastitis due to Staphylococcus aureus and related bacteria and it reduced the severity of the symptoms in the cows that had mastitis.
Estonian: Uuringud näitasid, et Startvac vähendas Staphylococcus aureus'e ja samalaadsete bakterite põhjustatud mastiiti põdevate lehmade arvu ja vähendas haiguse sümptomite raskust.
English: Other information about Startvac:
Estonian: Muu teave Startvaci kohta
English: The study compared cows that were given Startvac with those that were given placebo (a dummy vaccine) and looked at the number of cows with mastitis, the severity of mastitis symptoms, and milk production.
Estonian: Uuringus võrreldi Startvaci platseeboga (näiv ravim), uuriti mastiidiga lehmade arvu, mastiidi sümptomite raskust ja piimatoodangut.
English: What benefit has Startvac shown during the studies?
Estonian: Milles seisneb uuringute põhjal Startvaci kasulikkus?
English: What is Startvac?
Estonian: Mis on Startvac?
English: What is Startvac used for?
Estonian: Milleks Startvaci kasutatakse?
English: It is available as orodispersible tablets (5, 7.5, 10, 15 and 20 mg).
Estonian: Seda turustatakse suus dispergeeruvate tablettidena (5, 7,5, 10, 15 ja 20 mg).
English: The usual dose range is between 5 and 20 mg per day.
Estonian: Tavaline annusevahemik on 5-20 mg päevas.
English: The full EPAR for Olazax Disperzi can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Olazax Disperzi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Patients over 65 years of age and patients who reduced liver or kidney function may need a lower starting dose of 5 mg per day.
Estonian: Üle 65-aastased patsiendid ning neeru- ja maksapuudulikkusega patsiendid võivad vajada väiksemat algannust (5 mg ööpäevas).
English: The European Commission granted a marketing authorisation valid throughout the EU for Olazax Disperzi on 10 December 2009
Estonian: Euroopa Komisjon andis Olazax Disperzi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 10. detsembril 2009.
English: The recommended starting dose of Olazax Disperzi depends on the disease being treated: 10 mg per day is used in schizophrenia and in the prevention of manic episodes, and 15 mg per day in the treatment of manic episodes, unless it is used with other medicines, in which case the starting dose can be 10 mg per day.
Estonian: Olazax Disperzi soovituslik algannus sõltub ravitavast haigusest: skisofreenia korral ja maaniaepisoodide ennetamiseks kasutatakse annust 10 mg ööpäevas ning maaniaepisoodide raviks 15 mg ööpäevas, välja arvatud kasutamisel koos teiste ravimitega, mil algannus võib olla 10 mg ööpäevas.
English: Olazax Disperzi olanzapine
Estonian: Olazax Disperzi olansapiin
English: The Committee recommended that Olazax Disperzi be given marketing authorisation.
Estonian: Komitee soovitas anda ravimi Olazax Disperzi müügiloa.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Olazax Disperzi.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: Olazax Disperzi is used to treat adults with schizophrenia.
Estonian: Olazax Disperzit kasutatakse täiskasvanud patsientidel skisofreenia ravimiseks.
English: Because Olazax Disperzi is a generic medicine and is bioequivalent to the reference medicines, its benefit and risk are taken as being the same as the reference medicines.
Estonian: Et Olazax Disperzi on geneeriline ravim ja bioekvivalentne võrdlusravimitega, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimitel.
English: Olazax Disperzi is also effective in maintaining improvement in patients who have responded to an initial course of treatment.
Estonian: Olazax Disperzit saab kasutada ka esialgse ravivastusega patsientide paranemistulemuse efektiivseks säilitamiseks.
English: The CHMP concluded that, in accordance with EU requirements, Olazax Disperzi has been shown to have comparable quality and to be bioequivalent to Zyprexa and Zyprexa Velotab.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud Olazax Disperzi võrdväärne kvaliteet ja bioekvivalentsus ravimitega Zyprexa ja Zyprexa Velotab.
English: Olazax Disperzi is also used to treat moderate to severe manic episodes (extremely high mood) in adults.
Estonian: Samuti kasutatakse Olazax Disperzit mõõdukate ja raskete maaniaepisoodide (meeleolu äärmuslik tõus) raviks täiskasvanud patsientidel.
English: Olazax Disperzi is a medicine containing the active substance olanzapine.
Estonian: Olazax Disperzi on ravim, mis sisaldab toimeainena olansapiini.
English: Other information about Olazax Disperzi
Estonian: Muu teave Olazax Disperzi kohta
English: Because Olazax Disperzi is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicines, Zyprexa and Zyprexa Velotab.
Estonian: Et Olazax Disperzi on geneeriline ravim, piirdusid uuringud katsetega, milles näidati selle bioekvivalentsust võrdlusravimitega Zyprexa ja Zyprexa Velotab.
English: This is a summary of the European public assessment report (EPAR) for Olazax Disperzi.
Estonian: See on ravimi Olazax Disperzi Euroopa avaliku hindamisaruande kokkuvõte.
English: This means that Olazax Disperzi is similar to ‘reference medicines' already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotab.
Estonian: See tähendab, et Olazax Disperzi on sarnane võrdlusravimitega Zyprexa ja Zyprexa Velotab, millel juba on Euroopa Liidus müügiluba.
English: Olazax Disperzi is a ‘generic medicine'.
Estonian: Olazax Disperzi on geneeriline ravim.
English: For more information about treatment with Olazax Disperzi, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Olazax Disperziga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.Kokkuvõtte viimane uuendus: 07-2014.
English: What is Olazax Disperzi?
Estonian: Mis on Olazax Disperzi?
English: The active substance in Olazax Disperzi, olanzapine, is an antipsychotic medicine.
Estonian: Olazax Disperzi toimeaine olansapiin on antipsühhootikum.
English: Why has Olazax Disperzi been approved?
Estonian: Miks Olazax Disperzi heaks kiideti?
English: How is Olazax Disperzi used?
Estonian: Kuidas Olazax Disperzit kasutatakse?
English: What is Olazax Disperzi used for?
Estonian: Milleks Olazax Disperzit kasutatakse?
English: How has Olazax Disperzi been studied?
Estonian: Kuidas Olazax Disperzit uuriti?
English: What are the benefits and risks of Olazax Disperzi shown during the studies?
Estonian: Milles seisneb Olazax Disperzi kasulikkus ja mis riskid ravimiga kaasnevad?
English: CANADA
Estonian: KANADA
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 27/06/2017
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV Müügiloa esmase väljastamise kuupäev: 27/06/2017
English: ATCvet code: QI10AX.
Estonian: ATCvet kood: QI10AX
English: The effect of vaccine on reproductive performance has not been investigated.
Estonian: Vaktsiini mõju reproduktiivfunktsioonile ei ole uuritud.
English: Do not use in clinically diseased groups of fish.
Estonian: Mitte kasutada kliiniliselt haigestunud kalade rühmadel.
English: Name and address of the manufacturer of the biological active substance Elanco Canada Ltd
Estonian: Bioloogilise toimeaine tootja nimi ja aadress Elanco Canada Ltd
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Estonian: Abiained, mis on loetletud ravimi omaduste kokkuvõtte lõigus 6.1, on lubatud ained, millele komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 viidatakse kui ravimjääkide piirnorme mittenõudvatele, või määruse (EÜ) nr 470/2009 reguleerimisalasse mittekuuluvad, kui neid kasutatakse nii, nagu selles veterinaarravimis.
English: Transient changes in swimming behaviour, pigmentation and inappetence are very common and can be observed for up to 2, 7 and 9 days, respectively.
Estonian: Ajutised muutused ujumiskäitumises, pigmentatsioonis ning isutus on väga sagedased ning täheldatavad vastavalt kuni 2, 7 ja 9 päeva.
English: Do not mix with any other veterinary medicinal products prior to or during administration.
Estonian: Mitte segada teiste veterinaarravimitega enne manustamist või manustamise ajal.
English: Atlantic salmon (Salmo salar).
Estonian: Atlandi lõhe (Salmo salar).
English: Only healthy fish should be vaccinated.
Estonian: Vaktsineeritakse ainult terveid kalu.
English: Consideration should be made for the weight of the fish before the final selection is made.
Estonian: Enne lõplikku valikut tuleb võtta arvesse kala kehamassi.
English: Injection equipment should be calibrated and inspected regularly to ensure appropriate dosing of the fish.
Estonian: Kalale sobiva annustamise tagamiseks tuleb süstimisvahendeid regulaarselt kalibreerida ja kontrollida.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/16/197/001
Estonian: EU/2/16/197/001
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals ) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports).
Estonian: Kõrvaltoimete esinemissagedus on defineeritud järgnevalt: - väga sage (ühe ravikuuri jooksul ilmnes(id) kõrvaltoime(d) rohkem kui 1-l 10 looma hulgast) - sage (rohkem kui 1-l, kuid vähem kui 10-l loomal 100-st) - aeg-ajalt (rohkem kui 1-l, kuid vähem kui 10-l loomal 1000-st) - harv (rohkem kui 1-l, kuid vähem kui 10-l loomal 10,000-st) - väga harv (vähem kui 1-l loomal 10,000-st, kaasaarvatud üksikjuhud).
English: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with any other veterinary medicinal products.
Estonian: Sobimatus Sobivusuuringute puudumise tõttu ei tohi seda veterinaarravimit teiste veterinaarravimitega segada.
English: Connect the other end of the transfer tubing set to the vaccine injection equipment (gun).
Estonian: Ülekandevooliku teine ots ühendatakse vaktsiini süstimise vahendiga (püstol).
English: Based on a 25 g fish weight a standard 0.5 mm diameter 3mm depth needle is recommended to be used routinely.
Estonian: Kala kehamassi 25 g põhjal on soovitatav kasutada rutiinselt standardset 0,5 mm diameetriga, 3 mm sügavusega nõela.
English: CLYNAV stimulates active immunity against salmonid alphavirus subtype 3 (SAV3).
Estonian: CLYNAV stimuleerib aktiivset immuunsuse kujunemist lõhelaste alfaviiruse 3. alatüübi (SAV 3) vastu.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.05 ml dose contains:
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Iga 0,05 ml annus sisaldab